GENEVA & BOSTON--(BUSINESS WIRE)--Medimaps Group announced today that a novel method for improving osteoporotic fracture risk assessment, TBS iNsight®, is now available to clinicians in the United States through a partnership with Hologic, Inc. (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. Hologic is the global leader in the development and manufacture of Dual Energy X-Ray Absorptiometry (DXA) bone densitometry systems.
Medimaps Group – developers of the TBS iNsight® diagnostic tool – and Hologic, Inc. have reached an agreement to distribute TBS iNsight® in the United States and Canada leveraging Hologic’s extensive direct sales organization.
Help employers find you! Check out all the jobs and post your resume.
